A_DT
negative_JJ
regulatory_JJ
region_NN
containing_VBG
a_DT
glucocorticosteroid_NN
response_NN
element_NN
-LRB-_-LRB-
nGRE_NN
-RRB-_-RRB-
in_IN
the_DT
human_JJ
interleukin-1beta_NN
gene_NN
._.

Interleukin-1_NN
beta_NN
-LRB-_-LRB-
IL-1beta_NN
-RRB-_-RRB-
is_VBZ
one_CD
of_IN
the_DT
most_RBS
important_JJ
inflammatory_JJ
mediators_NNS
in_IN
human_JJ
inflammatory_JJ
and_CC
immunological_JJ
diseases_NNS
._.

The_DT
regulation_NN
of_IN
human_JJ
IL-1beta_NN
gene_NN
expression_NN
has_VBZ
been_VBN
studied_VBN
for_IN
several_JJ
years_NNS
,_,
and_CC
a_DT
few_JJ
regulatory_JJ
elements_NNS
have_VBP
been_VBN
discovered_VBN
in_IN
the_DT
promoter_NN
region_NN
._.

However_RB
,_,
little_JJ
is_VBZ
known_VBN
about_IN
negative_JJ
regulation_NN
of_IN
IL-1beta_NN
expression_NN
at_IN
the_DT
transcriptional_JJ
level_NN
,_,
which_WDT
may_MD
play_VB
an_DT
important_JJ
role_NN
in_IN
anti-inflammatory_JJ
and_CC
immunosuppressive_JJ
effects_NNS
._.

We_PRP
have_VBP
identified_VBN
a_DT
negative_JJ
regulatory_JJ
element_NN
located_JJ
in_IN
the_DT
region_NN
between_IN
-685_CD
and_CC
-395_CD
._.

Within_IN
this_DT
region_NN
,_,
a_DT
19-bp_JJ
nuclear_JJ
factor_NN
binding_NN
site_NN
-LRB-_-LRB-
-570_CD
to_TO
-552_CD
-RRB-_-RRB-
was_VBD
characterized_VBN
by_IN
DNase_NN
I_NN
footprinting_NN
and_CC
electromobility_NN
shift_NN
assay_NN
._.

A_DT
consensus_NN
sequence_NN
for_IN
a_DT
negative_JJ
glucocorticoid_NN
response_NN
element_NN
-LRB-_-LRB-
nGRE_NN
-RRB-_-RRB-
and_CC
a_DT
transcription_NN
activator_NN
protein-2_NN
binding_NN
site_NN
were_VBD
noted_VBN
within_IN
this_DT
footprint_NN
._.

Functional_JJ
studies_NNS
showed_VBD
a_DT
2.5-fold_JJ
increase_NN
in_IN
promoter_NN
activity_NN
when_WRB
this_DT
19-bp_JJ
binding_NN
site_NN
was_VBD
deleted_VBN
in_IN
the_DT
reporter_NN
constructs_NNS
IL-1beta_NN
\/_:
CAT_NN
and_CC
IL-1beta_NN
\/_:
SV40_NN
promoter\/CAT_NN
._.

Dexamethasone_NN
-LRB-_-LRB-
10_CD
-LRB-_-LRB-
-8_CD
-RRB-_-RRB-
M_NN
-RRB-_-RRB-
repressed_VBD
chloramphenicol_NN
acetyltransferase_NN
-LRB-_-LRB-
CAT_NN
-RRB-_-RRB-
production_NN
by_IN
75_CD
%_NN
in_IN
the_DT
wild-type_JJ
fragment_NN
but_CC
not_RB
in_IN
a_DT
deletion_NN
mutant_NN
lacking_VBG
the_DT
19-bp_JJ
site_NN
._.

A_DT
protein_NN
of_IN
about_RB
150_CD
kD_NN
that_WDT
bound_VBN
to_TO
this_DT
negative_JJ
regulatory_JJ
sequence_NN
was_VBD
identified_VBN
by_IN
UV_NN
cross-linking_NN
._.

This_DT
is_VBZ
the_DT
first_JJ
description_NN
of_IN
a_DT
negative_JJ
regulatory_JJ
region_NN
responsive_JJ
to_TO
glucocorticoids_NNS
in_IN
a_DT
cytokine_NN
gene_NN
._.

